Oral Semaglutide Demonstrates meaningful but generally smaller weight-loss effects Shows strong improvements in blood sugar control (HbA1c), particularly in diabetic populations Requires higher daily doses to compensate for lower absorption However, some studies point to similar outcomes in the short term
The medication continues to suppress appetite, and the health benefits, lower blood pressure, improved glucose control, reduced inflammation, persist as long as treatment continues
Pair this with elevated cortisol, insulin resistance, and chronic inflammation, and youve got a metabolic storm working against you
Novo Nordisk, Ozempics manufacturer, notes that the NovoFine Plus 32G 4 mm needles that come with Ozempic are the thinnest available needles for GLP-1 receptor agonists